172 related articles for article (PubMed ID: 34775358)
1. Nimbolide inhibits 2D and 3D prostate cancer cells migration, affects microtubules and angiogenesis and suppresses B-RAF/p.ERK-mediated in vivo tumor growth.
Mahmoud N; Dawood M; Huang Q; Ng JPL; Ren F; Wong VKW; Efferth T
Phytomedicine; 2022 Jan; 94():153826. PubMed ID: 34775358
[TBL] [Abstract][Full Text] [Related]
2. Nimbolide-Induced Oxidative Stress Abrogates STAT3 Signaling Cascade and Inhibits Tumor Growth in Transgenic Adenocarcinoma of Mouse Prostate Model.
Zhang J; Ahn KS; Kim C; Shanmugam MK; Siveen KS; Arfuso F; Samym RP; Deivasigamanim A; Lim LH; Wang L; Goh BC; Kumar AP; Hui KM; Sethi G
Antioxid Redox Signal; 2016 Apr; 24(11):575-89. PubMed ID: 26649526
[TBL] [Abstract][Full Text] [Related]
3. Nimbolide inhibits invasion and migration, and down-regulates uPAR chemokine gene expression, in two breast cancer cell lines.
Elumalai P; Brindha Mercy A; Arunkamar R; Sharmila G; Bhat FA; Balakrishnan S; Raja Singh P; Arunakaran J
Cell Prolif; 2014 Dec; 47(6):540-52. PubMed ID: 25377085
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of histone deacetylase 6 destabilizes ERK phosphorylation and suppresses cancer proliferation via modulation of the tubulin acetylation-GRP78 interaction.
Wattanathamsan O; Chantaravisoot N; Wongkongkathep P; Kungsukool S; Chetprayoon P; Chanvorachote P; Vinayanuwattikun C; Pongrakhananon V
J Biomed Sci; 2023 Jan; 30(1):4. PubMed ID: 36639650
[TBL] [Abstract][Full Text] [Related]
6. Nimbolide inhibits androgen independent prostate cancer cells survival and proliferation by modulating multiple pro-survival signaling pathways.
Singh PR; Priya ES; Balakrishnan S; Arunkumar R; Sharmila G; Rajalakshmi M; Arunakaran J
Biomed Pharmacother; 2016 Dec; 84():1623-1634. PubMed ID: 27889231
[TBL] [Abstract][Full Text] [Related]
7. Nimbolide, a limonoid triterpene, inhibits growth of human colorectal cancer xenografts by suppressing the proinflammatory microenvironment.
Gupta SC; Prasad S; Sethumadhavan DR; Nair MS; Mo YY; Aggarwal BB
Clin Cancer Res; 2013 Aug; 19(16):4465-76. PubMed ID: 23766363
[TBL] [Abstract][Full Text] [Related]
8. Nimbolide, a Neem Limonoid, Inhibits Angiogenesis in Breast Cancer by Abrogating Aldose Reductase Mediated IGF-1/PI3K/Akt Signalling.
Nivetha R; Arvindh S; Baba AB; Gade DR; Gopal G; K C; Reddy KP; Reddy GB; Nagini S
Anticancer Agents Med Chem; 2022; 22(14):2619-2636. PubMed ID: 35125086
[TBL] [Abstract][Full Text] [Related]
9. Nimbolide, a Neem Limonoid, Is a Promising Candidate for the Anticancer Drug Arsenal.
Nagini S; Nivetha R; Palrasu M; Mishra R
J Med Chem; 2021 Apr; 64(7):3560-3577. PubMed ID: 33739088
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of the supercritical extract of azadirachta indica (neem) leaves in vitro and in vivo on inhibition of prostate cancer tumor growth.
Wu Q; Kohli M; Bergen HR; Cheville JC; Karnes RJ; Cao H; Young CY; Tindall DJ; McNiven MA; Donkena KV
Mol Cancer Ther; 2014 May; 13(5):1067-77. PubMed ID: 24674886
[TBL] [Abstract][Full Text] [Related]
11. Dual STAT‑3 and IL‑6R inhibition with stattic and tocilizumab decreases migration, invasion and proliferation of prostate cancer cells by targeting the IL‑6/IL‑6R/STAT‑3 axis.
Méndez-Clemente A; Bravo-Cuellar A; González-Ochoa S; Santiago-Mercado M; Palafox-Mariscal L; Jave-Suárez L; Solorzano-Ibarra F; Villaseñor-García M; Ortiz-Lazareno P; Hernández-Flores G
Oncol Rep; 2022 Aug; 48(2):. PubMed ID: 35703345
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cell survival and proliferation by nimbolide in human androgen-independent prostate cancer (PC-3) cells: involvement of the PI3K/Akt pathway.
Raja Singh P; Sugantha Priya E; Balakrishnan S; Arunkumar R; Sharmila G; Rajalakshmi M; Arunakaran J
Mol Cell Biochem; 2017 Mar; 427(1-2):69-79. PubMed ID: 28025797
[TBL] [Abstract][Full Text] [Related]
13. Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition.
Subramani R; Gonzalez E; Arumugam A; Nandy S; Gonzalez V; Medel J; Camacho F; Ortega A; Bonkoungou S; Narayan M; Dwivedi Ak; Lakshmanaswamy R
Sci Rep; 2016 Jan; 6():19819. PubMed ID: 26804739
[TBL] [Abstract][Full Text] [Related]
14. Nimbolide suppresses non-small cell lung cancer cell invasion and migration via manipulation of DUSP4 expression and ERK1/2 signaling.
Lin H; Qiu S; Xie L; Liu C; Sun S
Biomed Pharmacother; 2017 Aug; 92():340-346. PubMed ID: 28554129
[TBL] [Abstract][Full Text] [Related]
15. Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
Yuan L; Huang X; Zhou K; Zhu X; Huang B; Qiu S; Cao K; Xu L
Prostate; 2019 Jun; 79(8):826-839. PubMed ID: 30889629
[TBL] [Abstract][Full Text] [Related]
16. Anti-proliferative and apoptosis inducing effect of nimbolide by altering molecules involved in apoptosis and IGF signalling via PI3K/Akt in prostate cancer (PC-3) cell line.
Raja Singh P; Arunkumar R; Sivakamasundari V; Sharmila G; Elumalai P; Suganthapriya E; Brindha Mercy A; Senthilkumar K; Arunakaran J
Cell Biochem Funct; 2014 Apr; 32(3):217-28. PubMed ID: 23963693
[TBL] [Abstract][Full Text] [Related]
17. A supercritical CO
Patel MJ; Tripathy S; Mukhopadhyay KD; Wangjam T; Cabang AB; Morris J; Wargovich MJ
Mol Carcinog; 2018 Sep; 57(9):1156-1165. PubMed ID: 29697164
[TBL] [Abstract][Full Text] [Related]
18. Insights into Nimbolide molecular crosstalk and its anticancer properties.
Shaheen S; Khalid S; Aaliya K; Gul A; Hafeez A; Armaghan M; Almarhoon ZM; Calina D; Khan K; Sharifi-Rad J
Med Oncol; 2024 May; 41(6):158. PubMed ID: 38761317
[TBL] [Abstract][Full Text] [Related]
19. Metastatic prostate cancer-associated P62 inhibits autophagy flux and promotes epithelial to mesenchymal transition by sustaining the level of HDAC6.
Jiang X; Huang Y; Liang X; Jiang F; He Y; Li T; Xu G; Zhao H; Yang W; Jiang G; Su Z; Jiang L; Liu L
Prostate; 2018 May; 78(6):426-434. PubMed ID: 29383752
[TBL] [Abstract][Full Text] [Related]
20. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis.
Chien MH; Lin YW; Wen YC; Yang YC; Hsiao M; Chang JL; Huang HC; Lee WJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):246. PubMed ID: 31182131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
